Disruption of the 12/15-lipoxygenase Gene Diminishes Atherosclerosis in Apo E-deficient Mice

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1999 Jun 8

PMID 10359569

Citations 142

Authors

T Cyrus

J L Witztum

D J Rader

R Tangirala

S Fazio

M F Linton

C D Funk

Affiliations

Soon will be listed here.

Abstract

Atherosclerosis may be viewed as an inflammatory disease process that includes early oxidative modification of LDLs, leading to foam cell formation. This "oxidation hypothesis" has gained general acceptance in recent years, and evidence for the role of lipoxygenases in initiation of, or participation in, the oxidative process is accumulating. However, the relative contribution of macrophage-expressed lipoxygenases to atherogenesis in vivo remains unknown. Here, we provide in vivo evidence for the role of 12/15-lipoxygenase in atherogenesis and demonstrate diminished plasma IgG autoantibodies to oxidized LDL epitopes in 12/15-lipoxygenase knockout mice crossbred with atherosclerosis-prone apo E-deficient mice (apo E-/-/L-12LO-/-). In chow-fed 15-week-old apo E-/-/L-12LO-/- mice, the extent of lesions in whole-aorta en face preparations (198 +/- 60 microm2) was strongly reduced (P < 0.001, n = 12) when compared with 12/15-lipoxygenase-expressing controls (apo E-/-/L-12LO+/+), which showed areas of lipid deposition (15,700 +/- 2,688 microm2) in the lesser curvature of the aortic arch, branch points, and in the abdominal aorta. These results were observed despite cholesterol, triglyceride, and lipoprotein levels that were similar to those in apo E-deficient mice. Evidence for reduced lesion development was observed even at 1 year of age in apo E-/-/L-12LO-/- mice. The combined data indicate a role for 12/15-lipoxygenase in the pathogenesis of atherosclerosis and suggest that inhibition of this enzyme may decrease disease progression.

Citing Articles

Regulation of nitric oxide generation and consumption.

Abu-Soud H, Camp O, Ramadoss J, Chatzicharalampous C, Kofinas G, Kofinas J Int J Biol Sci. 2025; 21(3):1097-1109.

PMID: 39897032 PMC: 11781162. DOI: 10.7150/ijbs.105016.

Genetic deletion of 12/15 lipoxygenase delays vascular remodeling and limits cardiorenal dysfunction after pressure overload.

Lee D, Kain V, Wang D, Rokosh D, Prabhu S, Halade G J Mol Cell Cardiol Plus. 2025; 5():100046.

PMID: 39802176 PMC: 11708313. DOI: 10.1016/j.jmccpl.2023.100046.

The Octadecanoids: Synthesis and Bioactivity of 18-Carbon Oxygenated Fatty Acids in Mammals, Bacteria, and Fungi.

Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C Chem Rev. 2024; 125(1):1-90.

PMID: 39680864 PMC: 11719350. DOI: 10.1021/acs.chemrev.3c00520.

Structural and Functional Biology of Mammalian ALOX Isoforms with Particular Emphasis on Enzyme Dimerization and Their Allosteric Properties.

Zhuravlev A, Gavrilyuk V, Chen X, Aksenov V, Kuhn H, Ivanov I Int J Mol Sci. 2024; 25(22).

PMID: 39596127 PMC: 11593649. DOI: 10.3390/ijms252212058.

Ferroptosis: A potential target of macrophages in plaque vulnerability.

Li Y, Ma J, Wang C, Zhou J, Sun Y, Wei X Open Life Sci. 2023; 18(1):20220722.

PMID: 37791060 PMC: 10543703. DOI: 10.1515/biol-2022-0722.

References

Pratico D, Barry O, Lawson J, Adiyaman M, Hwang S, Khanapure S . IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A. 1998; 95(7):3449-54. PMC: 19856. DOI: 10.1073/pnas.95.7.3449. View

Linton M, Atkinson J, Fazio S . Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995; 267(5200):1034-7. DOI: 10.1126/science.7863332. View

Watson A, Leitinger N, Navab M, Faull K, Horkko S, Witztum J . Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997; 272(21):13597-607. DOI: 10.1074/jbc.272.21.13597. View

Funk C . The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta. 1996; 1304(1):65-84. DOI: 10.1016/s0005-2760(96)00107-5. View

Yamamoto S . Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1992; 1128(2-3):117-31. DOI: 10.1016/0005-2760(92)90297-9. View

Chen X, Kurre U, Jenkins N, Copeland N, Funk C . cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem. 1994; 269(19):13979-87. View

Cushing S, Berliner J, Valente A, Territo M, Navab M, Parhami F . Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990; 87(13):5134-8. PMC: 54276. DOI: 10.1073/pnas.87.13.5134. View

Parthasarathy S, Printz D, Boyd D, Joy L, Steinberg D . Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 1986; 6(5):505-10. DOI: 10.1161/01.atv.6.5.505. View

Witztum J . The oxidation hypothesis of atherosclerosis. Lancet. 1994; 344(8925):793-5. DOI: 10.1016/s0140-6736(94)92346-9. View

10.

Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J . Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989; 320(14):915-24. DOI: 10.1056/NEJM198904063201407. View

11.

Leenen P, de Bruijn M, Voerman J, Campbell P, van Ewijk W . Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods. 1994; 174(1-2):5-19. DOI: 10.1016/0022-1759(94)90005-1. View

12.

Suarna C, Dean R, May J, Stocker R . Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995; 15(10):1616-24. DOI: 10.1161/01.atv.15.10.1616. View

13.

Parthasarathy S, Wieland E, Steinberg D . A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A. 1989; 86(3):1046-50. PMC: 286618. DOI: 10.1073/pnas.86.3.1046. View

14.

Sloane D, Leung R, Craik C, Sigal E . A primary determinant for lipoxygenase positional specificity. Nature. 1991; 354(6349):149-52. DOI: 10.1038/354149a0. View

15.

Bocan T, Rosebury W, Mueller S, Kuchera S, Welch K, Daugherty A . A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis. 1998; 136(2):203-16. DOI: 10.1016/s0021-9150(97)00204-9. View

16.

Takahashi Y, Glasgow W, Suzuki H, Taketani Y, Yamamoto S, Anton M . Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. Eur J Biochem. 1993; 218(1):165-71. DOI: 10.1111/j.1432-1033.1993.tb18362.x. View

17.

Kuhn H, Heydeck D, Hugou I, Gniwotta C . In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest. 1997; 99(5):888-93. PMC: 507896. DOI: 10.1172/JCI119253. View

18.

Benz D, Mol M, Ezaki M, Zelan I, Miyanohara A, Friedmann T . Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem. 1995; 270(10):5191-7. DOI: 10.1074/jbc.270.10.5191. View

19.

Yla-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T . Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest. 1995; 95(6):2692-8. PMC: 295952. DOI: 10.1172/JCI117971. View

20.

Heinecke J, Rosen H, Chait A . Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 1984; 74(5):1890-4. PMC: 425370. DOI: 10.1172/JCI111609. View